The mandates cover:
1) The acquisition of not more than 3,250,000 series A shares, whereof a maximum of 3,150,000 may be transferred to option holders under the performance based personnel option plan 2019.
2) The acquisition of not more than 30,000 series A shares, later to be sold on the market in connection with payment to Board members who have opted to receive synthetic shares as part of their remuneration.
3) The sale of not more than 15,000 series A shares to cover costs related to previously issued synthetic shares to Board members.
4) The sale of a maximum 7,900,000 series A and series B shares currently held by the company, for the purpose of covering costs of fulfilling obligations related to the performance based personnel option plans 2014, 2015 and 2016.
Repurchases and sales are subject to market conditions, regulatory restrictions and the capital structure at any given time.
The number of issued shares is presently 1,213,738,703 whereof 823,765,854 series A shares and 389,972,849 series B shares.